Login / Signup

Rationale and design of the IRON-AF study: a double-blind, randomised, placebo-controlled study to assess the effect of intravenous ferric carboxymaltose in patients with atrial fibrillation and iron deficiency.

Samuel J TuAdrian D ElliottNicole Hanna-RiveroCeline GallagherRicardo S MishimaEllen LyrtzisDanielle WlochowiczNicholas Ar ClarkeKurt C Roberts-ThomsonMichael B StokesMehrdad EmamiDennis H LauPrashanthan SandersChristopher X Wong
Published in: BMJ open (2021)
Australian New Zealand Clinical Trials Registry (ACTRN12620000285954).
Keyphrases
  • iron deficiency
  • clinical trial
  • double blind
  • open label
  • atrial fibrillation
  • study protocol
  • phase ii
  • placebo controlled
  • randomized controlled trial
  • phase iii